Browse Category

NYSE:HUM 5 February 2026 - 31 July 2026

For live price, interactive charts, financials and the latest market data, visit Google Finance.

Standalone Medicare Part D Plans Face Heightened 2027 Churn Risk as Subsidy Ends

Centene stands out as the insurer most exposed to the risks from the Medicare Part D subsidy phaseout. Approximately 90% of its prescription drug plan members are enrolled in standalone plans. The CMS will terminate the temporary premium policy following 2026.

31 July 2026

NYSE:CNC·NYSE:CVS·NYSE:HUM·NYSE:UNH·Stock Market

Humana’s Medicare Advantage overhaul involving 600,000 members eclipses Q2 earnings beat

Shares of Humana Inc. dropped on Wednesday, even after the company surpassed quarterly profit forecasts. The maintained guidance put the focus on a more substantial Medicare Advantage pullback projected for 2027.

29 July 2026

NYSE:HUM·Stock Market

Insurer Pricing Gap Grows as Medicare Part D Subsidy Set to Expire After 2026

The Trump administration plans to discontinue temporary assistance for stand-alone prescription drug plans, or PDPs, following 2026. Insurers will assume increased pricing risk starting next year as a result.

29 July 2026

NYSE:CNC·NYSE:CVS·NYSE:HUM·NYSE:UNH·Stock Market

Humana (NYSE:HUM) Shares Drop in Premarket After Outperforming Q2, 2026 Forecast Indicates Notable Second-Half Shift

Shares of Humana Inc. dropped approximately 8% ahead of Wednesday’s market open. The health insurer maintained its adjusted EPS floor for 2026 at $9.

29 July 2026

Earnings Reports·NYSE:HUM·Stock Market

Humana (NYSE: HUM) trades ahead of July 29 results

Humana dropped 3.6% by 1 p.m. Thursday, giving up an initial 4.1% rise at the open. The stock turned lower even as UnitedHealth Group posted strong results.

16 July 2026

Earnings Reports·NYSE:HUM·Stock Market

UnitedHealth Shares Climb as Wall Street Sees Less Cost Pressure

UnitedHealth Group shares climbed over 5% Thursday morning after Bank of America upgraded the stock to Buy and Morgan Stanley raised its price target. Wall Street is showing new support for the health insurer’s recovery bet.

4 June 2026

NYSE:CI·NYSE:ELV·NYSE:HUM·NYSE:UNH·Stock Market

UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

UnitedHealth Group shares climbed Tuesday, last changing hands at $396.45, up $12.01—roughly a 3.1% jump. The session saw some volatility: the stock kicked off at $383.68, dipped to $382.06, before momentum took over and bulls drove it up to $397.33 toward the close.

12 May 2026

NYSE:CI·NYSE:ELV·NYSE:HUM·NYSE:UNH·Stock Market

Humana Stock Jumps 11% as Medicare Advantage Hopes Put HUM Shares Back in Play

Shares of Humana Inc. surged 11.27% on Friday, finishing at $274.96. Investors zeroed in on cost trends across the U.S. managed-care space, driving the Medicare insurer’s stock sharply higher. HUM had ended Thursday at $247.12, according to Humana’s historical prices.

9 May 2026

NYSE:CVS·NYSE:ELV·NYSE:HUM·NYSE:UNH·Stock Market

Why Humana Stock’s 25% Rally Is Facing a Profit-Cut Reality Check

Humana’s stock comeback is hitting a snag. The insurer has cut its 2026 earnings forecast under U.S. accounting standards, yet investors keep betting on a Medicare Advantage turnaround that remains out of reach.

8 May 2026

NYSE:HUM·Stock Market

Humana Stock Drops After Earnings Beat: Medicare Advantage Headwind Keeps Pressure On

Humana Inc. topped Wall Street’s Q1 profit forecasts Wednesday. Still, shares slid over 6% premarket as the health insurer left its 2026 adjusted profit target untouched and cut its reported earnings guidance.

29 April 2026

Earnings Reports·NYSE:HUM·Stock Market

UnitedHealth Stock Jumps as Centene Results Put Insurer Turnaround Back in Play

UnitedHealth Group Incorporated saw its shares jump roughly 4% to $369.41 early Tuesday afternoon, lifted alongside other U.S. health insurers after Centene issued another profit outlook boost. Centene surged more than 14%. Humana and CVS Health picked up gains as well, as the latest guidance stoked hopes that the sector’s medical-cost crunch could be loosening its grip.

28 April 2026

NYSE:CNC·NYSE:CVS·NYSE:ELV·NYSE:HUM·NYSE:UNH·Stock Market

US Stock Market Today: S&P 500, Dow, Nasdaq Slip as Oil Jumps and Fed Uncertainty Caps Rally

Stocks faded into the red Tuesday afternoon, with renewed gains in oil and Treasury yields wiping out the morning’s strength. By early afternoon, the S&P 500 slipped 0.32% to 7,086.48. The Nasdaq Composite fell 0.29% to 24,334.67, and the Dow Jones Industrial Average dropped 0.27% to 49,307.73—each index had been in positive territory earlier.

21 April 2026

Federal Reserve·NASDAQ:AMZN·NASDAQ:TSLA·NYSE:BA·NYSE:CVS·NYSE:HUM·NYSE:JPM·NYSE:PG·NYSE:UNH·Oil Prices·Stock Market

UnitedHealth Stock Slides Again as April Earnings Loom, Putting UNH Valuation Under New Scrutiny

UnitedHealth Group shares dropped over 4% Friday, deepening losses that had already triggered fresh talk about valuation and next week's earnings after sinking 1.6% earlier in the week. The stock changed hands at $257.04 by mid-afternoon in New York.

27 March 2026

Earnings Reports·NYSE:CI·NYSE:ELV·NYSE:HUM·NYSE:UNH·Stock Market

Humana stock jumps 6% as Medicare Advantage enrollment report puts HUM back in focus

Humana Inc jumped 6.1% Thursday, finishing the day at $186.83 after moving within a range of $177.75 to $187.44. Even with the rally, shares remain down about 41% from their 52-week peak, but are sitting roughly 10% above the 52-week low.

27 February 2026

NYSE:HUM·Stock Market

UnitedHealth (UNH) stock price rises as markets slide — Medicare Advantage deadlines and Humana warning in focus

Shares of UnitedHealth Group jumped close to 2% Thursday, bucking a broad market downturn as investors sifted through new updates from the hard-hit U.S. managed-care space. The stock traded as high as $284.44 and as low as $275.86, settling near $284.37, up about 2%.

12 February 2026

NYSE:HUM·NYSE:UNH·Stock Market

Humana stock slips after Medicare star ratings hit 2026 profit outlook

Humana dropped 1.9% to $177.87 by midday Wednesday, after the health insurer said it expects 2026 profit to miss analyst targets. The company blamed softer government quality scores on its Medicare Advantage plans for the outlook.

11 February 2026

NYSE:HUM·Stock Market

UnitedHealth stock price slips after hours as investors brace for early-April Medicare rate call

UnitedHealth Group Inc dipped 0.3% to $275.70 in post-market trade Monday. The stock moved between $273.88 and $280.15 earlier in the day, with more than 10 million shares changing hands.

10 February 2026

NYSE:CI·NYSE:CVS·NYSE:HUM·NYSE:UNH·Stock Market

UnitedHealth stock heads into Monday after UNH’s 3% jump — what investors watch next

UnitedHealth Group Incorporated ended Friday with a 3% gain, finishing at $276.65. U.S. markets remain closed Sunday, so investors are already looking ahead to what might set the tone before the open on Monday.

8 February 2026

NYSE:CVS·NYSE:HUM·NYSE:UNH·Stock Market

UnitedHealth stock rebounds after hours as UNH recoups losses; Medicare rate debate looms

UnitedHealth Group Incorporated finished the regular session with a 3.4% gain, closing at $277.57. In late after-hours trading, the stock was holding up, last seen up nearly 3% at $276.65.

7 February 2026

NYSE:CNC·NYSE:HUM·NYSE:MOH·NYSE:UNH·Stock Market

UnitedHealth stock falls again after FTC insulin deal puts OptumRx back in focus

Shares of UnitedHealth Group Incorporated dropped roughly 3% on Wednesday, slipping to a session low of $274.04. In after-hours trading, the stock was last down 2.9%, trading at $275.92.

5 February 2026

NYSE:CI·NYSE:CVS·NYSE:ELV·NYSE:HUM·NYSE:UNH·Stock Market

1 2 3 Next

NYSE:HUM 5 February 2026 - 31 July 2026

Standalone Medicare Part D Plans Face Heightened 2027 Churn Risk as Subsidy Ends

Humana’s Medicare Advantage overhaul involving 600,000 members eclipses Q2 earnings beat

Insurer Pricing Gap Grows as Medicare Part D Subsidy Set to Expire After 2026

Humana (NYSE:HUM) Shares Drop in Premarket After Outperforming Q2, 2026 Forecast Indicates Notable Second-Half Shift

Humana (NYSE: HUM) trades ahead of July 29 results

UnitedHealth Shares Climb as Wall Street Sees Less Cost Pressure

UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

Humana Stock Jumps 11% as Medicare Advantage Hopes Put HUM Shares Back in Play

Why Humana Stock’s 25% Rally Is Facing a Profit-Cut Reality Check

Humana Stock Drops After Earnings Beat: Medicare Advantage Headwind Keeps Pressure On

UnitedHealth Stock Jumps as Centene Results Put Insurer Turnaround Back in Play

US Stock Market Today: S&P 500, Dow, Nasdaq Slip as Oil Jumps and Fed Uncertainty Caps Rally

UnitedHealth Stock Slides Again as April Earnings Loom, Putting UNH Valuation Under New Scrutiny

Humana stock jumps 6% as Medicare Advantage enrollment report puts HUM back in focus

UnitedHealth (UNH) stock price rises as markets slide — Medicare Advantage deadlines and Humana warning in focus

Humana stock slips after Medicare star ratings hit 2026 profit outlook

UnitedHealth stock price slips after hours as investors brace for early-April Medicare rate call

UnitedHealth stock heads into Monday after UNH’s 3% jump — what investors watch next

UnitedHealth stock rebounds after hours as UNH recoups losses; Medicare rate debate looms

UnitedHealth stock falls again after FTC insulin deal puts OptumRx back in focus

TechStock² Updates

Amphenol share split shifts attention to $1.9 billion order buffer

Palo Alto Networks (NASDAQ:PANW) Jumps 10% as Analysts Focus on Organic Growth

Banco Bradesco S.A. (BVMF:BBDC4) shares drop under rights issue price amid credit cost pressures

DraftKings Inc. (NASDAQ:DKNG) surges 8% as analysts say half-point margin boost could offset Q2 shortfall

SK hynix Shares Under Scrutiny Monday Amid $38 Billion Factory Move, Cash Returns in Focus

Top Stock Picks

Constellation Energy

AerCap

Walt Disney

AIG

Cheniere Energy

Live updates

Investment Disclaimer